Diffusion and mathematical modeling of release profiles from nanocarriers

被引:93
作者
Cruz, L
Soares, LU
Dalla Costa, T
Mezzalira, G
da Silveira, NP
Guterres, SS
Pohlmann, AR
机构
[1] Univ Fed Rio Grande Sul, Inst Quim, Programa Posgrad Quim, BR-91501970 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande Sul, Fac Pharm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil
关键词
nanoparticles; nanocapsules; indomethacin; alkaline hydrolysis; poly(epsilon-caprolactone); indomethacin ethyl ester;
D O I
10.1016/j.ijpharm.2006.01.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to establish models and to differentiate the kinetic release behavior of drug models from nanocapsules, nanoemulsion and nanospheres by physico-chemical characterization and release experiments. SAXS analysis showed that the polymer is organized in the nanocapsules, while in the nanospheres the sorbitan monostearate is organized and acts as an impurity of the poly(epsilon--caprolactone) suggesting that constituents in these nanocarriers are differently organized. Formulations presented particle sizes ranging from 178 to 297 nm, probe content from 0.981 to 0.997 mg/mL, pH values from 4.90 to 5. 10 and zeta potential from -37.9 to -51.9 mV. The kinetic experiments showed that the nanostructures present similar behaviors when the probe is adsorbed on the nanocarriers (indomethacin-loaded formulations). However, when the probe is entrapped within the nanocarriers (indomethacin ethyl ester-loaded formulations), nanocapsules, nanospheres and nanoemulsion presented different kinetic behaviors. Mathematical modeling of the release profiles was conducted, showing that the presence of the polymer increases the half-lives of the burst phases (5.9, 4.4 and 2.7 min) while the presence of the oil increases the half-lives of the sustained phases (288.8, 87.7 and 147.5 min) for nanocapsules, nanospheres and nanoemulsion, respectively. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:198 / 205
页数:8
相关论文
共 43 条
  • [1] Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics
    Allémann, E
    Leroux, JC
    Gurny, R
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) : 171 - 189
  • [2] Skin penetration and distribution of polymeric nanoparticles
    Alvarez-Román, R
    Naik, A
    Kalia, Y
    Guy, RH
    Fessi, H
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 99 (01) : 53 - 62
  • [3] INVITRO RELEASE KINETIC PATTERN OF INDOMETHACIN FROM POLY(D,L-LACTIDE) NANOCAPSULES
    AMMOURY, N
    FESSI, H
    DEVISSAGUET, JP
    PUISIEUX, F
    BENITA, S
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (09) : 763 - 767
  • [4] AMMOURY N, 1993, CLIN MATER, V13, P121, DOI 10.1016/0267-6605(93)90098-R
  • [5] UPTAKE CAPACITY AND ADSORPTION-ISOTHERMS OF DOXORUBICIN ON POLYMERIC NANOPARTICLES - EFFECT OF METHODS OF PREPARATION
    BAPAT, N
    BOROUJERDI, M
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (01) : 65 - 77
  • [6] RECENT ADVANCES ON THE USE OF BIODEGRADABLE MICROPARTICLES AND NANOPARTICLES IN CONTROLLED DRUG-DELIVERY
    BRANNONPEPPAS, L
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (01) : 1 - 9
  • [7] ADSORPTION OF HEMATOPORPHYRIN ONTO POLYALKYLCYANOACRYLATE NANOPARTICLES - CARRIER CAPACITY AND DRUG RELEASE
    BRASSEUR, N
    BRAULT, D
    COUVREUR, P
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 70 (1-2) : 129 - 135
  • [8] Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers
    Calvo, P
    VilaJato, JL
    Alonso, MJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (05) : 530 - 536
  • [9] CHASTEIGNER S, 1995, STP PHARMA SCI, V5, P242
  • [10] Nanocapsule technology: A review
    Couvreur, P
    Barratt, G
    Fattal, E
    Legrand, P
    Vauthier, C
    [J]. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2002, 19 (02): : 99 - 134